Benjamin Brown

Benjamin Brown is a seasoned executive with significant expertise in pharmacovigilance, genomics, and health technology. As the Founder and Executive Director of the American Society of Pharmacovigilance, Benjamin established the STRIPE Collaborative Community, the first FDA-recognized group focused on pharmacogenomics, while advocating for patient safety and precision medicine at various governmental levels. Additional leadership roles include serving as Co-Chairman of the Pharmacogenomics Access & Reimbursement Coalition and as a member of the ISCC Pharmacogenomics Working Group, where Benjamin contributes to enhancing genomic literacy among healthcare providers. As the Founder and CEO of Dynamic Life Sciences, Benjamin focuses on improving patient outcomes through innovative health technologies. Previous experience includes advisory roles in wealth management and investment analysis, along with a Bachelor’s degree in Economics and Finance from Southern Methodist University.